Mukka Proteins Limited
Mukka Proteins Limited manufactures and sells fish protein products in India. The company offers fish meal, oil, and soluble paste; and ento meal, oil, and soil. It also provides insect meal, oil, and compost; and humic acid. The company's products are used for aqua feed, poultry feed, pet feed, EPADHA extraction, animal feed, soap manufacture, leather tanneries, and paint industries. It also exp… Read more
Mukka Proteins Limited (MUKKA) - Total Liabilities
Latest total liabilities as of September 2025: ₹7.77 Billion INR
Based on the latest financial reports, Mukka Proteins Limited (MUKKA) has total liabilities worth ₹7.77 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Mukka Proteins Limited - Total Liabilities Trend (2019–2025)
This chart illustrates how Mukka Proteins Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Mukka Proteins Limited Competitors by Total Liabilities
The table below lists competitors of Mukka Proteins Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
AMCON Distributing Company
NYSE MKT:DIT
|
USA | $264.60 Million |
|
Ting Sin Co Ltd
TW:2358
|
Taiwan | NT$2.10 Billion |
|
Gold Pacific Co. Ltd
KQ:038530
|
Korea | ₩8.14 Billion |
|
East Africa Metals Inc
PINK:EFRMF
|
USA | $4.38 Million |
|
Cintac
SN:CINTAC
|
Chile | CL$459.47 Million |
|
Nsys Co. Ltd.
KQ:333620
|
Korea | ₩34.37 Billion |
|
Mister Spex SE
F:MRX
|
Germany | €102.07 Million |
|
Big River Industries Ltd
AU:BRI
|
Australia | AU$145.90 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Mukka Proteins Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Mukka Proteins Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Mukka Proteins Limited (2019–2025)
The table below shows the annual total liabilities of Mukka Proteins Limited from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹6.20 Billion | +16.40% |
| 2024-03-31 | ₹5.32 Billion | +22.91% |
| 2023-03-31 | ₹4.33 Billion | +45.67% |
| 2022-03-31 | ₹2.97 Billion | +4.31% |
| 2021-03-31 | ₹2.85 Billion | +21.14% |
| 2020-03-31 | ₹2.35 Billion | +50.16% |
| 2019-03-31 | ₹1.57 Billion | -- |